Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older
Condition(s):OsteopeniaLast Updated:September 12, 2016Completed
Hide Studies Not Open or Pending
Condition(s):OsteopeniaLast Updated:September 12, 2016Completed
Condition(s):Cancer; Childhood CancerLast Updated:January 17, 2024Recruiting
Condition(s):MACS SyndromeLast Updated:December 27, 2023Completed
Condition(s):Asthma; Osteoporosis, Osteopenia; Osteoporosis Risk; Osteoporotic FracturesLast Updated:February 26, 2024Recruiting
Condition(s):Cystic Fibrosis-related DiabetesLast Updated:November 29, 2023Completed
Condition(s):OsteoporosisLast Updated:July 10, 2020Unknown status
Condition(s):GoutLast Updated:October 4, 2021Unknown status
Condition(s):OsteoporosisLast Updated:September 23, 2021Recruiting
Condition(s):Healthy; Premature Ovarian FailureLast Updated:May 16, 2013Completed
Condition(s):Multiple MyelomaLast Updated:August 10, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.